Abstract
Introduction and Aim: Due to a lack of effective medications, beta-thalassemia is a serious issue in Iraq. Thus, the current investigation aimed to explore the relationship between TNF-alpha gene polymorphism G/A (rs 1800629), Vitamin D (Vit D), Calcium (Ca), alkaline phosphatase (ALP), and ferritin status in Iraqi beta thalassemia major and intermediate patients.
Materials and Methods: Blood samples were collected from 46 patients suffering from thalassemia major (TM) plus 48 patients suffering from thalassemia intermediate (TI) and 48 of apparently healthy volunteers as control group aged 18-60 years, from Ibn Al-Baladi Hospital, Baghdad.
Results: Studies for the distribution of TNF- alpha G/A (rs 1800629) genotype showed that among TM patients and TI patients, the prevalence of the mutant AA genotype (rs 1800629) was higher in TM patients, while in the control group, it was lower. Similarly, for the wild genotype (GG), the prevalence was highest in control group followed by T1 and TM patients. The frequency of A allele was high in TM patients, while the G allele frequency was more in the control group. Results also showed that the TNF- alpha genotype variations influenced Vitamin D, Calcium, ALP, and ferritin levels in TM and TI patients, wherein the patients with TNF-alpha mutant genotype (AA) were associated with highest levels of ferritin and ALP among all genotypes groups, while the patients of with TNF-alpha wild genotype (GG) were associated with high levels of Vitamin D and Calcium among all genotypes groups.
Conclusion: Patients with at least one copy of (A) allele had a higher risk of TM and TI and there was an association between the heterogeneous (GA) and mutant (AA) genotypes, also presence of (A) allele with status differences of Vit D, Ca, ALP, and ferritin in Iraqi beta thalassemia major and intermediate patients.
Publisher
Indian Association of Biomedical Scientists
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference25 articles.
1. Higgs, D., Engel, J., Stamatoyannopoulos, G. Thalassemia. The lancet. 2012; 379(9813): 373-383.
2. Mustafa, I., Firdous, N., Shebl, F., Shi, Z., Saeed, M., Zahir, Z. et al., Genetic epidemiology of beta-thalassemia in the Maldives: 23 years of a beta-thalassemia screening program. Gene. 2020; 741:144544.
3. Jwaid, S., Gata, A. Comparison study of major thalassemia, thalassemia intermedia of Iraqi patients and control groups for effectiveness of liver enzymes. Medico Legal Update Journal, 2020; 20(1):1181-1184.
4. Uglialoro, A., Turbay, D., Pesavento, P., Delgado, J., McKenzie F., Gribben J. et al., Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue antigens. 1998; 52: 359-367.
5. Locksley, R., Killeen, N., Lenardo, M. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001; 104(4): 487-501.